Filed before 2025Filed 20 January 2022
Equilibre BioPharmaceuticals Corp. raised $15.9M
Equilibre BioPharmaceuticals Corp., a pharmaceuticals company based in New York, NY, raised $15.9M in a new equity round, according to a filing dated 20 January 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 20 January 2022
- Round
- Equity round
- Amount sold
- $15.9M
- Offering size
- $25M
- Investors so far
- 14
- Based in
- New York, NY
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 65% of the 1,764 tracked raises with an amount filed in 2022, and than 61% of the 38 in pharmaceuticals.
Equilibre BioPharmaceuticals Corp. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 1 Dec 2022 | Amended filing | $6M | Another raise |
| 1 Dec 2022 | New filing | $6M | Another raise |
| 20 Jan 2022 | New filing | $15.9M | This raise |
| 12 Nov 2020 | New filing | $25.8M | Another raise |
More with Panther Micro on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.